Trials / Completed
CompletedNCT05343468
Life Skills Improved in Children With Down Syndrome After Using Assistive Technology
Independence, Quality of Life, and Adaptive Behavioral Skills Improved in Children With Down Syndrome After Using Assistive Technology
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- MapHabit, Inc. · Industry
- Sex
- All
- Age
- 7 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Enhancing independence and quality of life are key modifiable outcomes that are short- and long-term goals for children with Down syndrome (DS) and for their parents. The study investigated the efficacy of assistive technology in improving children with Down Syndrome's independence and quality of life. Using a commercially available assistive technology, the MapHabit system, the investigators implemented the software with participants' families for 4 weeks. The investigators hypothesized that the assistive technology will improve adaptive behavioral skills and overall quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The MapHabit System | The MapHabit System (MHS) is a commercially available visual mapping software application that utilize visual, audio, and text media to create step-by-step visual guides to assist individuals and their caregivers in structuring and accomplishing activities of daily living (ADLs). The goal of the application is to develop and facilitate habits and routines using structured visual and auditory stimuli that can be customized by the user and can include educational and lesson-based material in addition to ADLs. The application was made available to families through compatible smartphones and tablets. The MHS is a general wellness product and there is no regulatory oversight of the MapHabit System mapping functionality. This functionality is not a regulated medical device. |
Timeline
- Start date
- 2020-09-20
- Primary completion
- 2021-06-18
- Completion
- 2021-08-05
- First posted
- 2022-04-25
- Last updated
- 2023-02-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05343468. Inclusion in this directory is not an endorsement.